Neogen Chemicals Limited IPO Message Board (Page 24)

@ mr harit
If gmp is 25-27 should we buy or sell

Small Size ipo are always risky
To trade at gmp
Allotments hard to get and lower gmp can trap you to square off your trade

Listing gain arround 1000 to 1200

what is the source of this rate

Gmp 15 so we atleast earn 1000 or 1200 or 1400or 1600 confirm .
Buyer in gra

Mujhe NCD me invest karna he.
Kaun se NCD me invest karu?
seniors please guide me.

thanks in advance

Thanks

JM Financial NCD opens next week. Invest there.

Better buy polycab in the secondary market @ 650 than this

Though this IPO may fully subscribe due to penny size but it will not give any listing gain and list around 170-180.
So please don't apply in this.

Went for the Mumbai Roadshow. Amazing Management. My guess people will be surprised with the nos going fwd. All quality long term investors must apply.

Aa gaye naya account banake..

look like company people creating id & promoting

I think highly overvalued fair value near 140

Less than 180rs is good bet

Exactly.

This IPO could be a good on fundamental basis. As this company is involved in making Lithium chemicals. Lithium chemicals are mostly ban in China and also foresee Electric vehicle market this could be a good company look into. Let's wait for few days and see what's Anchor investors think about this. Rajesh K. Bothra

215 is too much high.
price should not be more than 180.
Lead managers are not so popular.
Also ' T ' group stock.So no grey market activity.
Avoid this IPO.Many good IPOs are in the pipeline.

Good point.. This IPO is complete avoid.

An off-context query (but important one) to all respected members:

I had some cash amount in my equity account after some of my share's sale proceeds (say amount A = X + Y); so I placed a payout request for an amount (say X) on 16April, 2019 and on the same day I did some trading against margin (say M, where M < Y).

Y is the amount I left in my equity trading account, which was way above than the margin 'M' amount required for trading whose bill was dated on 22 April, 2019. Which I intended to pay any time before the due date.

But in any case these are two separate transactions and should not be linked. As I have done trading in the past on margin and always paid for delivery much well before the due date.

I also have a few lakhs worth of shares still in the demat A/c operated through this broker as our DP.

The broker has refused to pay my X amount today and reasons that as I have an upcoming bill pending on 22 April, 2019, hence I can not withdraw X. Here X is much bigger than the total bill (almost 30 times bigger that total bill which would be due on 22 April).

So my query is: Is it okay and legal for the broker to show his discretion on linking two separate transactions (both transactions are well within the terms & conditions of operations of my trading a/c with them)?

If not, what are my options now?

Regards,
Praveen Prasad

@215 PE is 27 which is not so good for an IPO.
I have already given a profit comparison with Fine Organics. Pros may buy at their own strategy. Others may rethink before buying.

Neogen Chemicals IPO - *Market Estimates of oversubscription*:

RII = 1.5L Forms = 4.53X Applic. wise (Avg allotment of ~14.36 shares per lot)
NII = 1K Crs. = ~50X

Interest cost @7%p.a. for 7days = 28.863paise for 1X

Thus, for NII the costing = 50 X 28.863paise = Rs.14.50 per share (GMP)

And, for RII the costing = 14.50 X 14.36 = Rs. ~245/- (Kostak)

Neogen Chemicals IPO - *GMP Expected*
GMP 15/-
Kostak 250/-

GMP 14/-
Negligible Trade in Neogen.
IPO is priced at PAR.
Hence Nothing to Cheer!!

Dear Raja,
Price seems little high.Please provide your views Apply or not

'T' group listing. Nobody mentioned this.

again look like promoters trying to use the Market all time high and listing of last 3 ipo's.................pricing highly...........

Absolutely..

behti ganga meh haath dho liye

It's over priced

I will not apply .

..
Neogen Chemicals IPO - Schedule (Pg #456 of RHP)

18th April - Price Band to be Announced
23rd April - Anchor List
24th April - Offer Opens
26th April - Offer Closes
03rd May - Finalisation of Basis of Allotment
06th May - Unblocking of ASBA
07th May - Credit to Demat Accounts
08th May - Listing on NSE & BSE


Neogen Chemicals IPO - Issue Information *(FINAL)*

Issue Opens on: 24 April 2019
Issue Closes on: 26 April 2019
Issue Type: Book Built Issue IPO
Issue Size: 65,84,210 Equity Shares
Face Value: Rs 10 per Equity Share
Issue Price: Rs.212 - Rs.215 per Equity Share
Market Lot: 65 shares
Listing At: NSE, BSE

Equity Shares outstanding prior to the Issue = 2,00,78,793 Equity Shares
Fresh Issue of 32,55,813 Equity Shares @215 = Rs.70.00 Crores
Offer for Sale of 29,00,000 Equity Shares @215 = Rs.62.35 Crores
Equity Shares outstanding after the Issue = 2,33,34,606 Equity Shares

Category-wise Break up:.
Anchor - 28,46,744 Shares = 39.70Crs
QIB - 12,31,163 Shares = 26.47Crs
NII - 9,23,372 Shares = 19.85Crs
RII - 21,54,535 Shares = 46.32Crs (Lot size: 65 = 33,147 Forms)
Total Issue - 61,55,813 Equity Shares = 132.45Crs.

Subscription required for 1X
RII = 33,147 Forms
NII = 19.85Crs

Interest cost @7.0%p.a. for 7days = 28.863paise for 1X


Neogen Chemicals IPO - Financial Information (Basis of Valuation)

EPS for FY15-16 >>> Rs.02.59 (Page #115 of RHP)
EPS for FY16-17 >>> Rs.03.84 (Page #115 of RHP)
EPS for FY17-18 >>> Rs.05.25 (Page #115 of RHP)
EPS for 9M18-19 >>> Rs.06.09 (Page #115 of RHP)

RoNW for FY15-16 >>> 18.80% (Page #117 of RHP)
RoNW for FY16-17 >>> 18.31% (Page #117 of RHP)
RoNW for FY17-18 >>> 20.97% (Page #117 of RHP)
RoNW for 9M18-19 >>> 19.88% (Page #117 of RHP)

NAV as on March 31, 2018 was Rs.25.12 (Page #117 of RHP)
NAV as on December 31, 2018 was Rs.30.62 (Page #117 of RHP)

Listed Industry Peer Group (Page #118 of RHP):
Aarti Industries
Atul Industries
Navin Flourine
Paushak
Vinati Organics